Studies Examine Association Between Recreational Marijuana Legalization, Changes in Traffic Fatality Rates

JAMA Internal Medicine

EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, JUNE 22, 2020

Media advisory: The full studies and commentary are linked to this news release.

 

Embed this link to provide your readers free access to the full-text article by Santaella-Tenorio and colleagues This link will be live at the embargo time https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2020.1757?guestAccessKey=2e788cd9-d78f-43ac-97d1-121a639e2fdc&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=062220

Embed this link to provide your readers free access to the full-text article by Kamer and colleagues This link will be live at the embargo time https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2020.1769?guestAccessKey=55702ba9-61c9-42de-8639-11dfa70b0fa6&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=062220

 

What The Studies Did: These studies looked at changes in the rate of traffic fatalities in states that have legalized the use of recreational cannabis.

 

Authors: Julian Santaella-Tenorio, Dr.P.H., of the New York University School of Medicine, is the corresponding author of the original investigation.

(doi:10.1001/jamainternmed.2020.1757)

Authors: Russell S. Kamer, M.D., of New York Medical College in White Plains, New York, is the corresponding author of the research letter.

(doi:10.1001/jamainternmed.2020.1769)

 

Editor’s Note: Please see the articles for additional information, including other authors, author contributions and affiliations, conflicts of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.